Search Ontology:
ChEBI

1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine

Term ID
CHEBI:73873
Synonyms
  • (2R)-3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate
  • 1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine
  • 1-Docosahexaenoyl-glycero-3-phosphocholine
  • LPC 22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0
  • LPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
  • Lyso(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
  • LysoPC 22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0
  • lysophosphatidylcholine(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
Definition
A lysophosphatidylcholine 22:6 in which the remaining acyl group is (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl.
References
  • HMDB:HMDB0010404
  • LIPID_MAPS_instance:LMGP01050056
  • Reaxys:7238344
Ontology
ChEBI  ( EBI )
Relationships
is a type of
has_functional_parent
has_role
Phenotype
Phenotype resulting from 1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine
Phenotype where environments contain 1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine
Phenotype modified by environments containing 1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine
Human Disease Model